» Articles » PMID: 8011282

Lymphokine Production by Human T Cells in Disease States

Overview
Date 1994 Jan 1
PMID 8011282
Citations 243
Authors
Affiliations
Soon will be listed here.
Abstract

A large body of evidence suggests the existence of polarized human T cell responses, reminiscent of Th1 and Th2 subsets described for mouse T cells. Human Th1-like cells preferentially develop during infections by intracellular bacteria, protozoa, and viruses, whereas Th2-like cells predominate during helminthic infestations and in response to common environmental allergens. The cytokine profile of "natural immunity" evoked by different offending agents in the context of different host genetic backgrounds appears to be a critical factor in determining the phenotype of the subsequent specific response. Strongly polarized human Th1-type and Th2-type responses not only play different roles in protection, they can also promote different immunopathological reactions. Th1-type responses appear to be involved in organ specific autoimmunity, in contact dermatitis, and in some chronic inflammatory disorders of unknown etiology. In contrast, in genetically predisposed hosts, Th2-type responses against common environmental allergens are responsible for triggering of allergic atopic disorders. Altered profiles of lymphokine production may account for immune dysfunctions in some primary or acquired immunodeficiency syndromes. The role of lymphokines produced by T cells in the pathogenesis of systemic autoimmune disorders is less clear. Further work is also required to better clarify the role of T cell-derived lymphokines in protecting against tumors or in favoring their development.

Citing Articles

Shear Stress Conditioning Promotes a Pro-Inflammatory Response in Porcine Endocardial Endothelial Cells.

Ji P, Grande-Allen K, Balaji S, Birla R, Keswani S bioRxiv. 2025; .

PMID: 39975174 PMC: 11838557. DOI: 10.1101/2025.02.03.636291.


An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease.

Li J, Long H, Chen S, Zhang Z, Li S, Liu Q Vaccines (Basel). 2025; 13(1).

PMID: 39852831 PMC: 11768429. DOI: 10.3390/vaccines13010052.


Gut‑liver axis in liver disease: From basic science to clinical treatment (Review).

Wang J, Wang X, Zhuo E, Chen B, Chan S Mol Med Rep. 2024; 31(1).

PMID: 39450549 PMC: 11541166. DOI: 10.3892/mmr.2024.13375.


Estimation of inflammatory cytokines in maternal serum for assessing the outcome of threatened miscarriage.

Lawal H, Obajimi G, Bello Y, Onifade A, Jimoh M, Arowojolu A J West Afr Coll Surg. 2024; 14(3):280-288.

PMID: 38988423 PMC: 11232791. DOI: 10.4103/jwas.jwas_136_23.


Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target.

Zhang M, Liu C, Li Y, Li H, Zhang W, Liu J Front Cell Dev Biol. 2024; 11:1332205.

PMID: 38264357 PMC: 10803597. DOI: 10.3389/fcell.2023.1332205.